INNOGENE Co.,Ltd. (KOSDAQ:344860)
South Korea · Delayed Price · Currency is KRW 1,692.00
+10.00 (0.59%)
At close: Feb 5, 2026
INNOGENE Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2019 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '19 Dec 31, 2019 |
Operating Revenue | 7,854 | 8,945 | 10,101 | 9,139 | 9,385 | 5,644 |
Other Revenue | - | - | - | - | -0 | -0 |
| 7,854 | 8,945 | 10,101 | 9,139 | 9,385 | 5,644 | |
Revenue Growth (YoY) | -23.88% | -11.45% | 10.52% | -2.62% | 66.29% | -27.72% |
Cost of Revenue | 2,021 | 2,325 | 2,781 | 2,363 | 2,069 | 1,533 |
Gross Profit | 5,833 | 6,620 | 7,320 | 6,776 | 7,316 | 4,111 |
Selling, General & Admin | 5,328 | 5,305 | 5,418 | 4,723 | 4,411 | 3,420 |
Research & Development | 289.86 | 413.69 | 429.08 | 326.76 | 308.72 | 420.7 |
Amortization of Goodwill & Intangibles | 14.95 | 5.35 | 2.72 | 14.73 | 24.76 | 32.04 |
Other Operating Expenses | 100.55 | 101.17 | 100.02 | 86.79 | 87.33 | 82.15 |
Operating Expenses | 5,905 | 5,990 | 6,094 | 5,289 | 4,918 | 4,365 |
Operating Income | -71.72 | 630.49 | 1,226 | 1,488 | 2,399 | -253.84 |
Interest Expense | -5.15 | -7.08 | -6.18 | -4.91 | -4.08 | -23.41 |
Interest & Investment Income | 367.27 | 480.1 | 386.35 | 49.62 | 8.13 | 1.81 |
Currency Exchange Gain (Loss) | 8.45 | 11.28 | 9.21 | 6.23 | 9.97 | 10.26 |
Other Non Operating Income (Expenses) | -46.19 | 16.53 | 90.32 | 6.55 | 23.78 | -84.43 |
EBT Excluding Unusual Items | 252.66 | 1,131 | 1,706 | 1,545 | 2,436 | -349.61 |
Gain (Loss) on Sale of Assets | -8.21 | -8.21 | - | - | - | 0.98 |
Asset Writedown | - | - | -0.06 | - | - | - |
Pretax Income | 244.45 | 1,123 | 1,706 | 1,545 | 2,436 | -348.63 |
Income Tax Expense | 14.99 | 177.96 | 309.84 | 205.76 | 178.6 | 63.72 |
Net Income | 229.46 | 945.16 | 1,396 | 1,339 | 2,258 | -412.34 |
Net Income to Common | 229.46 | 945.16 | 1,396 | 1,339 | 2,258 | -412.34 |
Net Income Growth | -81.33% | -32.30% | 4.24% | -40.68% | - | - |
Shares Outstanding (Basic) | 12 | 12 | 12 | 9 | 9 | 0 |
Shares Outstanding (Diluted) | 12 | 12 | 12 | 9 | 9 | 0 |
Shares Change (YoY) | -3.91% | 2.78% | 25.09% | 0.10% | 4345.68% | 0.12% |
EPS (Basic) | 19.95 | 79.04 | 120.00 | 144.00 | 243.00 | -1973.01 |
EPS (Diluted) | 19.95 | 79.04 | 120.00 | 144.00 | 243.00 | -1973.01 |
EPS Growth | -80.57% | -34.13% | -16.67% | -40.74% | - | - |
Free Cash Flow | 934.64 | 809.15 | 2,188 | 550.24 | 2,168 | 430.12 |
Free Cash Flow Per Share | 81.26 | 67.67 | 188.08 | 59.16 | 233.31 | 2058.07 |
Gross Margin | 74.27% | 74.01% | 72.47% | 74.14% | 77.95% | 72.84% |
Operating Margin | -0.91% | 7.05% | 12.14% | 16.28% | 25.56% | -4.50% |
Profit Margin | 2.92% | 10.57% | 13.82% | 14.65% | 24.06% | -7.31% |
Free Cash Flow Margin | 11.90% | 9.05% | 21.66% | 6.02% | 23.10% | 7.62% |
EBITDA | 168.91 | 856.66 | 1,457 | 1,723 | 2,629 | 8.88 |
EBITDA Margin | 2.15% | 9.58% | 14.42% | 18.85% | 28.01% | 0.16% |
D&A For EBITDA | 240.62 | 226.17 | 230.39 | 235.28 | 230.4 | 262.72 |
EBIT | -71.72 | 630.49 | 1,226 | 1,488 | 2,399 | -253.84 |
EBIT Margin | -0.91% | 7.05% | 12.14% | 16.28% | 25.56% | -4.50% |
Effective Tax Rate | 6.13% | 15.85% | 18.16% | 13.32% | 7.33% | - |
Advertising Expenses | - | 1,081 | 904.43 | 788.77 | 584.7 | 79.78 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.